NCT04472156 A Prospective Study of a Mosaic Embryo Transfer
| NCT ID | NCT04472156 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Colorado Center for Reproductive Medicine |
| Condition | Infertility |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2020-10-15 |
| Primary Completion | 2026-06-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2020-10-15 with a primary completion date of 2026-06-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research is a prospective study in which the purpose is to investigate the clinical outcomes following the transfer of a mosaic embryo (presence of both chromosomally normal and abnormal cells) that has been screened for preimplantation genetic testing (PGT).
Eligibility Criteria
Inclusion Criteria: * Women age 18-45 Infertile women who have completed an IVF cycle with PGT at the Colorado Center for Reproductive Medicine (CCRM) that have a mosaic embryo * Patients can be of any race, culture, sexual orientation or ethnicity * Patients that are willing to transfer a single embryo Exclusion Criteria: * Patients that do not meet the clinical requirements for an embryo transfer per clinic standards. * Patients that desire more than a single embryo transfer. * Patients that are using a gestational carrier. * Embryonic mosaic PGT results that include chromosome errors 13, 18, 21 * Patients that did not complete their IVF with PGT cycle at the Colorado Center for Reproductive Medicine.
Contact & Investigator
Mandy Katz-Jaffe, PhD
PRINCIPAL INVESTIGATOR
Fertility Genetics
Frequently Asked Questions
Who can join the NCT04472156 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Infertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04472156 currently recruiting?
Yes, NCT04472156 is actively recruiting participants. Contact the research team at rmakloski@colocrm.com for enrollment information.
Where is the NCT04472156 trial being conducted?
This trial is being conducted at Lone Tree, United States.
Who is sponsoring the NCT04472156 clinical trial?
NCT04472156 is sponsored by Colorado Center for Reproductive Medicine. The principal investigator is Mandy Katz-Jaffe, PhD at Fertility Genetics. The trial plans to enroll 250 participants.